# Red Blood Cell Precursor Formulation to Determine Increased Production

> **NCT01701531** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Targeted Medical Pharma**

## Conditions studied

- Anemia

## Interventions

- **DRUG:** RBCPF

## Key facts

- **NCT ID:** NCT01701531
- **Lead sponsor:** Targeted Medical Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-10
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding not received
- **Last updated:** 2016-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01701531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01701531, "Red Blood Cell Precursor Formulation to Determine Increased Production". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01701531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*